378 related articles for article (PubMed ID: 26055970)
1. Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation.
Sharma N; Nehru B
Neurochem Int; 2015 Aug; 87():92-105. PubMed ID: 26055970
[TBL] [Abstract][Full Text] [Related]
2. Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson's Disease Model.
Sharma N; Nehru B
Mol Neurobiol; 2016 Jul; 53(5):3326-3337. PubMed ID: 26081143
[TBL] [Abstract][Full Text] [Related]
3. Apocyanin, NADPH oxidase inhibitor prevents lipopolysaccharide induced α-synuclein aggregation and ameliorates motor function deficits in rats: Possible role of biochemical and inflammatory alterations.
Sharma N; Kapoor M; Nehru B
Behav Brain Res; 2016 Jan; 296():177-190. PubMed ID: 26367469
[TBL] [Abstract][Full Text] [Related]
4. Curcumin protects dopaminergic neurons against inflammation-mediated damage and improves motor dysfunction induced by single intranigral lipopolysaccharide injection.
Sharma N; Sharma S; Nehru B
Inflammopharmacology; 2017 Jun; 25(3):351-368. PubMed ID: 28409389
[TBL] [Abstract][Full Text] [Related]
5. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models.
Tai W; Ye X; Bao X; Zhao B; Wang X; Zhang D
Neuropharmacology; 2013 Dec; 75():201-12. PubMed ID: 23916477
[TBL] [Abstract][Full Text] [Related]
8. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice.
Deng I; Corrigan F; Garg S; Zhou XF; Bobrovskaya L
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299000
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra.
Arimoto T; Choi DY; Lu X; Liu M; Nguyen XV; Zheng N; Stewart CA; Kim HC; Bing G
Neurobiol Aging; 2007 Jun; 28(6):894-906. PubMed ID: 21887889
[TBL] [Abstract][Full Text] [Related]
10. The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation.
Iravani MM; Leung CC; Sadeghian M; Haddon CO; Rose S; Jenner P
Eur J Neurosci; 2005 Jul; 22(2):317-30. PubMed ID: 16045485
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide-induced functional and structural injury of the mitochondria in the nigrostriatal pathway.
Hunter R; Ojha U; Bhurtel S; Bing G; Choi DY
Neurosci Res; 2017 Jan; 114():62-69. PubMed ID: 27667002
[TBL] [Abstract][Full Text] [Related]
12. Further characterisation of the LPS model of Parkinson's disease: a comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat.
Hoban DB; Connaughton E; Connaughton C; Hogan G; Thornton C; Mulcahy P; Moloney TC; Dowd E
Brain Behav Immun; 2013 Jan; 27(1):91-100. PubMed ID: 23044176
[TBL] [Abstract][Full Text] [Related]
13. Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model.
Sharma N; Nehru B
Inflammopharmacology; 2018 Apr; 26(2):349-360. PubMed ID: 29027056
[TBL] [Abstract][Full Text] [Related]
14. Pro-inflammatory cytokine-mediated ferroportin down-regulation contributes to the nigral iron accumulation in lipopolysaccharide-induced Parkinsonian models.
Zhang Z; Hou L; Song JL; Song N; Sun YJ; Lin X; Wang XL; Zhang FZ; Ge YL
Neuroscience; 2014 Jan; 257():20-30. PubMed ID: 24183966
[TBL] [Abstract][Full Text] [Related]
15. Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle.
Norazit A; Meedeniya AC; Nguyen MN; Mackay-Sim A
Brain Res; 2010 Nov; 1360():119-29. PubMed ID: 20807515
[TBL] [Abstract][Full Text] [Related]
16. Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage and oxidative stress in a rat model of Parkinson's disease.
Wang J; He C; Wu WY; Chen F; Wu YY; Li WZ; Chen HQ; Yin YY
Pharmacol Biochem Behav; 2015 Nov; 138():96-103. PubMed ID: 26394281
[TBL] [Abstract][Full Text] [Related]
17. Modulation of M1/M2 polarization by capsaicin contributes to the survival of dopaminergic neurons in the lipopolysaccharide-lesioned substantia nigra in vivo.
Bok E; Chung YC; Kim KS; Baik HH; Shin WH; Jin BK
Exp Mol Med; 2018 Jul; 50(7):1-14. PubMed ID: 29968707
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive study on long-term injury to nigral dopaminergic neurons following intracerebroventricular injection of lipopolysaccharide in rats.
Zhou Y; Zhang Y; Li J; Lv F; Zhao Y; Duan D; Xu Q
J Neurochem; 2012 Dec; 123(5):771-80. PubMed ID: 22957701
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action.
Park HJ; Lee PH; Ahn YW; Choi YJ; Lee G; Lee DY; Chung ES; Jin BK
Eur J Neurosci; 2007 Jul; 26(1):79-89. PubMed ID: 17581257
[TBL] [Abstract][Full Text] [Related]
20. Altered glutathione homeostasis in animals prenatally exposed to lipopolysaccharide.
Zhu Y; Carvey PM; Ling Z
Neurochem Int; 2007 Mar; 50(4):671-80. PubMed ID: 17291629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]